# Gerresheimer acquires Sensile Medical for up to EUR 350M

Gerresheimer is acquiring Swiss technology company Sensile Medical AG for a maximum purchase price of EUR 350 million, with an initial payment of EUR 175 million. The acquisition extends Gerresheimer's business model toward OEM drug delivery platforms with digital and electronic capabilities.

- Type: Acquisition
- Announced: 2018-07-11
- Where: Olten, Switzerland, Switzerland
- Value: $410.0M (350.0M EUR)
- Status: announced
- Products: drug delivery platforms, inhalers, prefillable syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Gerresheimer](https://endata.com/companies/1928.md) (acquirer)
- [Sensile Medical](https://endata.com/companies/32785.md) (target)

## Sources

- [gerresheimer.com](https://www.gerresheimer.com/en/customer/company/news/detail/gerresheimer-extends-business-model-and-increases-growth-forecast), 2018-07-11: "With the acquisition of Sensile Medical, Gerresheimer is extending its business model in the direction of an Original Equipment Manufacturer (OEM) for drug delivery platforms with digital and electronic capabilities for pharmaceutical and biopharmaceutical customers."
- [dcatvci.org](https://www.dcatvci.org/top-industry-news/gerresheimer-to-acquire-sensile-medical-for-409-million/), 2018-08-01: "Gerresheimer says it is extending its business model in the direction of an original equipment manufacturer (OEM) for drug-delivery platforms"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.